SCHEMBL30962810

SCHEMBL30962810

COc1nc(Nc2ccc(C3CCN(C)CC3)c(C)c2)nc(-c2c(F)cccc2Cl)c1C(N)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ WEE1 P30291 2/20 0.44
▸ ALK Q9UM73 2/20 0.41
▸ HTR1F P30939 1/20 0.40
▸ AURKA O14965 1/20 0.40
▸ AURKB Q96GD4 1/20 0.40
▸ EHMT2 Q96KQ7 1/20 0.39
▸ MAP4K1 Q92918 1/20 0.39
▸ JAK2 O60674 3/20 0.38
▸ JAK1 P23458 2/20 0.38
▸ JAK3 P52333 2/20 0.38
▸ TYK2 P29597 1/20 0.38
▸ PIK3CD O00329 1/20 0.37
▸ CSF1R P07333 1/20 0.37
▸ CDK4 P11802 1/20 0.37
▸ CDK6 Q00534 1/20 0.37
▸ PTK2 Q05397 4/20 0.37
▸ LMNA P02545 1/20 0.37
▸ GLA P06280 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30962797 0.95 WEE1 (0.47) WEE1ALKEHMT2JAK2CDK4
SCHEMBL30962777 0.94 WEE1 (0.46) WEE1ALKHTR1FEHMT2JAK2
SCHEMBL30962936 0.92 WEE1 (0.41) WEE1ALKHTR1FEHMT2JAK2
SCHEMBL30962727 0.92 ALK (0.45) WEE1ALKAURKAAURKBEHMT2
SCHEMBL30962948 0.92 ALK (0.40) WEE1ALKEHMT2MAP4K1JAK2
SCHEMBL30962694 0.91 WEE1 (0.44) WEE1ALKEHMT2MAP4K1JAK2
SCHEMBL30962784 0.91 ALK (0.41) WEE1ALKEHMT2MAP4K1JAK2
SCHEMBL30962824 0.91 WEE1 (0.42) WEE1ALKHTR1FEHMT2JAK2
SCHEMBL30962806 0.90 WEE1 (0.43) WEE1ALKEHMT2JAK3PTK2
SCHEMBL30962877 0.90 WEE1 (0.44) WEE1ALKEHMT2JAK2CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4642767-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS Acrivon Therapeutics, Inc. (US) 2025-11-05 — — EP disclosed
WO-2024145505-A1 PYRIMIDINE CARBOXAMIDE COMPOUNDS ACRIVON THERAPEUTICS, INC. (US) 2024-07-04 — — WO disclosed
Send feedback